Pancreatic cancer news
US researchers have found a link between the makeup of bacteria in the tumours of people with pancreatic cancer and how long they live.
A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.
A dual kinase inhibitor is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine.
Scientists have found a new way in which cells that surround pancreatic cancers in mice can help the tumours grow.
Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage.